Member Info for Livedataaccount

Avacta are scheduled to have an interview on 7th Monday next week with Third Bridge.
One of the bullet points is "expectations for outcomes of phase 1a"
This strikes me as positive

I see Avacta are down for a interview with Third Bridge 11/6/22 (us date)

- targeted chemotherapy precision overview
- expectations for phase 1a outcomes and commercialisation opportunities

Keep it up, Hurst.

Are Avacta already in receipt of the funds from the convertible bond? What date will the launxh diagnoatics acquisition close? I couldn't find the date in the rns.
Thanks in advance

Are BEGO buying?

BEGO?

BEGO?

This is very positive for me. They wouldn't arrange this if it wasn't good news.

The Company looks forward to providing a full technical update to shareholders on the Affimer immunotherapy and pre|CISION chemotherapy programmes as part of a Science Day event when the data sets from the pre-clinical and clinical programmes are in hand, so that the data can be presented and the development path and associated risks for the programmes can be described in detail.

Anyone from BEGO there?

Thanks, hurstbot

I wouldn't recommend inserting plastic into your sphincter.

Hence there has been no rns about when the results will be.
Waiting for the this last cohort to finish.

Quite possible the Americans got up early

Someone just arrived home from Esmo or asco?

I wish I'd never posted the link now!! Lol

Americans be online soon

Bego on the bid

Chin up, Timster
Bego might be back on the bid soon

It didn't sound particularly rhetorical, beinthelead.

Soft tissue sarcoma not sickle cell

Number 7 in list of yesterday's appovals